16
Views
0
CrossRef citations to date
0
Altmetric
Correspondence

Centralised faecal blood testing for both screening and pathology requests

Pages 700-704 | Published online: 17 Nov 2010

  • Australian Health Technology Advisory Committee (AHTAC). Colorectal Cancer Screening. Canberra: Commonwealth Department of Health and Family Services, 1997.
  • National Cancer Control Initiative (NCCI). Screening for Early Detection of Colorectal Cancer: A National Initiative for the New MillenniumMelbourne: NCCI, 1999.
  • Australian Institute of Health and Welfare (AIHW). National Bowel Cancer Screening Program Monitoring Report 2008Canberra: AIHW, 2008; AIHW cat. no. CAN 40. http://www.aihw.gov.au/publications/index.cfm/title/10665 .
  • Winawer SJ, Sherlock P, Schottenfeld D, et al Results of a screening program for the detection of early colon cancer and polyps using fecal occult blood testing. Gastroenterology 1977; 72: 127–50.
  • Mandel JS, Bond JH, Church TR, et al Reducing mortality from colorectal cancer by screening for occult blood. N Engl J Med 1993; 328: 1365–71.
  • Hardcastle JD, Thomas WM, Chamberlain J, et al Randomised controlled trial of faecal occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472–7.
  • Kronberg O, Fenger C, Sondergaard O, et al Initial mass screening for colorectal cancer with fecal ocult blood test. Scand J Gastroenterol 1987; 22: 677–86.
  • Kewenter J, Bjork S, Haglind E, et al Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27,000 subjects. Cancer 1988; 62: 645–51.
  • Stevenson C. Screening for Bowel Cancer: Results of the Australian Pilot Study Australian Institute of Health and Welfare Presented at Moving Forward on Bowel Cancer Screening in Asutralia. Victoria, Australia, November 2006.
  • Macrae FA. Providing colonoscopy services for the National Bowel Cancer Screening Program. Med J Aust 2007; 186: 280–1.
  • Fujirebio Inc. Magstream 1000/Hem SP-Technical Dossier October 2005Tokyo: Fujirebio Inc, 2005; (provided by Bayer Health Care Diagnostics Division).
  • Edwards JB, Williams JAR, Thomas DW. Experiences in providing a screening service for colorectal cancer from a pathology laboratory. Pathology 2004; 36: 1–5.
  • Levi Z, Rozen P, Hazazi R, et al A quantitative immunochemical fecal occult blood test for colorectal hyperplasia. Ann Intern Med 2007; 146: 244–55.
  • Sinatra MA, St John DJB, Young GP. Interference of plant peroxidises with guaiac based fecal occult blood tests is avoidable. Clin Chem 1999; 45: 123–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.